Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Posters Mar 3, 2026
Mass Spectrometry

March 3, 2026

Luca Genovesi, Mark Watson, Gwenael Pottiez

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Featured Resources

See All Experts' Insights
WRIB 2 Posters
Apr 14, 2026

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS
Picture2 Posters
Mar 3, 2026

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry
Poster: microsampling with intact-mass HRMS for M-protein monitoring and MRD in myeloma. Posters
Nov 10, 2025

Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?
See All Experts' Insights

One global CRO for your whole therapeutic development journey

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Talk to our Team
cta banner